Evidence map›Paper›PMID 34156923›Full record

ArticleMicrobial genomics2021

Genomic epidemiology of the first epidemic wave of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Palestine.

Nouar Qutob, Zaidoun Salah, Damien Richard, Hisham Darwish, Husam Sallam, Issa Shtayeh, Osama Najjar, Mahmoud Ruzayqat, Dana Najjar, François Balloux and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbial genomics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Tracking of SARS-CoV-2 Alpha variant (B.1.1.7) in Palestine.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2022
    Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Nouar QutobDepartment of Health Sciences, Faculty of Graduate Studies, Arab American University, Ramallah, Palestine.
Zaidoun SalahDepartment of Health Sciences, Faculty of Graduate Studies, Arab American University, Ramallah, Palestine.
Damien RichardInstitute of Child Health, University College London, London, UK.
Hisham DarwishDepartment of Health Sciences, Faculty of Graduate Studies, Arab American University, Ramallah, Palestine.
Husam SallamDepartment of Health Sciences, Faculty of Graduate Studies, Arab American University, Ramallah, Palestine.
Issa ShtayehPalestinian Ministry of Health, Ramallah, Palestine.
Osama NajjarPalestinian Ministry of Health, Ramallah, Palestine.
Mahmoud RuzayqatPalestinian Ministry of Health, Ramallah, Palestine.
Dana NajjarDepartment of Health Sciences, Faculty of Graduate Studies, Arab American University, Ramallah, Palestine.
François BallouxUCL Genetics Institute, University College London, London, UK.
Lucy van DorpUCL Genetics Institute, University College London, London, UK.
Arab American University · PSUniversity College London · GBAl-Quds University · PS

Funding

Biotechnology and Biological Sciences Research Council BB/R01356X/1
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel coronavirus responsible for the COVID-19 pandemic, continues to cause a significant public-health burden and disruption globally. Genomic epidemiology approaches point to most countries in the world having experienced many independent introductions of SARS-CoV-2 during the early stages of the pandemic. However, this situation may change with local lockdown policies and restrictions on travel, leading to the emergence of more geographically structured viral populations and lineages transmitting locally. Here, we report the first SARS-CoV-2 genomes from Palestine sampled from early March 2020, when the first cases were observed, through to August of 2020. SARS-CoV-2 genomes from Palestine fall across the diversity of the global phylogeny, consistent with at least nine independent introductions into the region. We identify one locally predominant lineage in circulation represented by 50 Palestinian SARS-CoV-2, grouping with genomes generated from Israel and the UK. We estimate the age of introduction of this lineage to 05/02/2020 (16/01/2020-19/02/2020), suggesting SARS-CoV-2 was already in circulation in Palestine predating its first detection in Bethlehem in early March. Our work highlights the value of ongoing genomic surveillance and monitoring to reconstruct the epidemiology of COVID-19 at both local and global scales.

Indexed as

ArabsCOVID-19Genome, ViralHigh-Throughput Nucleotide SequencingHumansIsraelMiddle EastPandemicsPhylogenyPhylogeographySARS-CoV-2Sequence Analysis, RNAUnited KingdomCOVID-19genomic epidemiologyminor allele frequencyphylogeneticswithin-host genetic diversity

Identifiers

PMID34156923
PMCPMC8461465
OpenAlexW3174450820

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.